338 related articles for article (PubMed ID: 7694818)
1. Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.
Hess AD; Horwitz LR; Laulis MK; Fuchs E
Clin Immunol Immunopathol; 1993 Dec; 69(3):341-50. PubMed ID: 7694818
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression.
Fischer AC; Ruvolo PP; Burt R; Horwitz LR; Bright EC; Hess JM; Beschorner WE; Hess AD
J Immunol; 1995 Apr; 154(8):3713-25. PubMed ID: 7706714
[TBL] [Abstract][Full Text] [Related]
3. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
Ohajekwe OA; James T; Hardy MA; Oluwole SF
Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
[TBL] [Abstract][Full Text] [Related]
4. The lesions of cyclosporine-induced autoimmune disease can be equally well elicited by CD4 or CD8 effector T cells.
Beijleveld LJ; Damoiseaux JG; Roglic M; Theofilopoulos AN; van Breda Vriesman PJ
Transplantation; 1996 Nov; 62(10):1468-76. PubMed ID: 8958274
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
Chen W; Thoburn C; Hess AD
J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
[TBL] [Abstract][Full Text] [Related]
6. Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules.
Hess AD; Thoburn CJ; Chen W; Bright AE
Transplantation; 2003 Apr; 75(8):1361-7. PubMed ID: 12717231
[TBL] [Abstract][Full Text] [Related]
7. Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease: specificity of cytolytic effector T cells.
Hess AD; Thoburn C; Horwitz L
Transplantation; 1998 Mar; 65(6):785-92. PubMed ID: 9539089
[TBL] [Abstract][Full Text] [Related]
8. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
Hess AD; Fischer AC; Beschorner WE
J Immunol; 1990 Jul; 145(2):526-33. PubMed ID: 1973185
[TBL] [Abstract][Full Text] [Related]
9. Effect of cyclosporine on T lymphocyte development. Relationship to syngeneic graft-versus-host disease.
Fischer AC; Laulis MK; Horwitz L; Hess AD
Transplantation; 1991 Jan; 51(1):252-9. PubMed ID: 1898996
[TBL] [Abstract][Full Text] [Related]
10. Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.
Hess AD; Horwitz L; Beschorner WE; Santos GW
J Exp Med; 1985 Apr; 161(4):718-30. PubMed ID: 2580038
[TBL] [Abstract][Full Text] [Related]
11. Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.
Hess AD; Thoburn CJ; Chen W; Horwitz LR
Biol Blood Marrow Transplant; 2000; 6(1):13-24. PubMed ID: 10707995
[TBL] [Abstract][Full Text] [Related]
12. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
Drobyski WR; Majewski D
Blood; 1996 Jun; 87(12):5355-69. PubMed ID: 8652851
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to clinically manifest cyclosporine A (CsA)-induced autoimmune disease is associated with interferon-gamma (IFN-gamma)-producing CD45RC+RT6- T helper cells.
Beijleveld LJ; Groen H; Broeren CP; Klatter FA; Kampinga J; Damoiseaux JG; van Breda Vriesman PJ
Clin Exp Immunol; 1996 Sep; 105(3):486-96. PubMed ID: 8809139
[TBL] [Abstract][Full Text] [Related]
14. Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Barrett TA; Bluestone JA; Vallera DA
Blood; 1996 Jan; 87(2):827-37. PubMed ID: 8555509
[TBL] [Abstract][Full Text] [Related]
15. Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells.
Hess AD; Thoburn CJ
Biol Blood Marrow Transplant; 2006 May; 12(5):518-29. PubMed ID: 16635787
[TBL] [Abstract][Full Text] [Related]
16. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
Thoburn CJ; Miura Y; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Sep; 10(9):591-603. PubMed ID: 15319771
[TBL] [Abstract][Full Text] [Related]
17. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
18. Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat.
Geller RB; Esa AH; Beschorner WE; Frondoza CG; Santos GW; Hess AD
Blood; 1989 Aug; 74(3):1165-71. PubMed ID: 2502208
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous immunopathology of cyclosporin-A-induced autoimmunity in the rat.
Damoiseaux JG; Beijleveld LJ; van Breda Vriesman PJ
Clin Immunol Immunopathol; 1995 Dec; 77(3):315-23. PubMed ID: 7586742
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K
J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
